Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Induction chemoradiation for rectal cancer.

Nancy Han1, Susan Galandiuk

  • 1Section of Colon and Rectal Surgery, Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40292, USA.

Archives of Surgery (Chicago, Ill. : 1960)
|December 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evolution of Colorectal Surgery Training.

Clinics in colon and rectal surgery·2026
Same author

EPICERTIN, an engineered variant of cholera toxin B subunit, promotes survival and a pro-remodeling macrophage phenotype for mucosal healing in colitis.

Mucosal immunology·2026
Same author

The Maroon DCR Website Banner: A Cache of Valuable Content-Part II.

Diseases of the colon and rectum·2025
Same author

The Maroon DCR Website Banner: A Cache of Valuable Content-Part I.

Diseases of the colon and rectum·2025
Same author

Transformations.

Diseases of the colon and rectum·2025
Same author

Itaconate and obesity-related hormones promote tumor progression - new insights on metabolic dysfunction in early-onset colon cancer.

Frontiers in immunology·2025

Neoadjuvant chemoradiation therapy significantly improves survival and reduces local recurrence for rectal cancer patients. Future advancements promise better outcomes with fewer side effects.

Area of Science:

  • Oncology
  • Gastroenterology

Background:

  • Rectal cancer poses significant treatment challenges.
  • Neoadjuvant therapy is a critical component of rectal cancer management.

Purpose of the Study:

  • To review the application, outcomes, and recent developments of neoadjuvant chemoradiation therapy for rectal cancer.

Main Methods:

  • Literature search of MEDLINE and PubMed (post-1980).
  • Inclusion of relevant English-language articles, excluding case reports.

Main Results:

  • Neoadjuvant chemoradiation demonstrated improved survival rates.
  • A significant decrease in local recurrence was observed in Stage II and III rectal cancers.

Conclusions:

Related Experiment Videos

  • Neoadjuvant chemoradiation is effective for Stage II and III rectal cancer.
  • Anticipated advances in chemotherapy and radiation therapy will enhance oncologic results and reduce toxicity.